Leiomyosarcoma (LMS) Not Yet Recruiting Phase 1 / 2 Trials for Abemaciclib (DB12001)

Back to Leiomyosarcoma (LMS)

Also known as: LMS - Leiomyosarcoma / Leiomyosarcomas / Leiomyosarcoma / Leiomyosarcoma (morphologic abnormality) / Leiomyosarcoma NOS / Leiomyosarcoma (disorder)

Indication	Status	Phase
DBCOND0118909 (Leiomyosarcoma (LMS))	Not Yet Recruiting	1 / 2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT06498648	Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma	Treatment	Abemaciclib (DB12001) Docetaxel (DB01248) Gemcitabine (DB00441)